ArticleNature communications2025
Afterglow ice formed by phosphorescent luminophore-protein conjugates and complexes in aqueous solution at freezing temperature.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Unlike the widely reported fluorophore-biomacromolecule systems in nucleic acid testing and immunoassay, organic afterglow luminophore-biomacromolecule conjugates and complexes remain rarely explored. Here we report the observation of organic afterglow from aqueous solutions of luminophore-protein conjugates and complexes at freezing temperature, named as afterglow ice for abbreviation. Reliable N-hydroxysuccinimide ester protocol, as well as β-diketone chemistry, are applied for protein labeling to form luminophore-protein conjugates, which exhibit intriguing afterglow at freezing temperature. Control experiments reveal that hydrophobic interaction and covalent linkage between luminophore and protein can protect organic triplet excited states from quenching. In the case of luminophore-protein complex, we observe the switching-on of organic afterglow after specific recognition of streptavidin by biotinylated luminophore, which is the example of specific recognition and sensing of biomacromolecules by organic afterglow emitters. Although it is not yet a mature technology for biomedical applications, this study represents the initial step of organic afterglow materials towards bio-labeling and bioassay fields, as well as expanding the application scenarios of bioactive products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.